Results 151 to 160 of about 235,541 (221)

Anterior Segment Optical Coherence Tomography Evaluation of a Dexamethasone Intravitreal Implant in the Crystalline Lens: A Case Report. [PDF]

Int Med Case Rep J
Santos-Oliveira J, Teixeira-Martins R, Ferreira AM, Macedo JP, Oliveira-Ferreira C.   +4 more
europepmc   +1 more source

Effectiveness and safety of fluocinolone acetonide intravitreal implant in diabetic macular edema patients considered insufficiently responsive to available therapies (REACT): a prospective, non-randomized, and multicenter study. [PDF]

Int Ophthalmol, 2023
Ruiz-Moreno JM, Adán A, Lafuente M, Asencio Durán M, Arias Barquet L, García Layana A, Araiz Iribarren J.   +6 more
europepmc   +1 more source

What have we learned from a decade treating patients with diabetic macular oedema with 0.19 mg fluocinolone acetonide intravitreal implant? [PDF]

Eye (Lond)
Kodjikian L, Duarte L, Singh P, Habib M, Gonzalez V.   +4 more
europepmc   +1 more source

Dexamethasone intravitreal implant monotherapy in naive patients with macular edema secondary to retinal vein occlusion: long term follow-up retrospective cohort study. [PDF]

Int J Ophthalmol
Karataş G, Çakır A, Uzundede T, Aday Ö, Özoğuz AM, Karataş ME, Kabakcı AK.   +6 more
europepmc   +1 more source

Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis. [PDF]

Indian J Ophthalmol, 2022
Elhamaky TR.
europepmc   +1 more source

Predictive Value of Optical Coherence Tomography Biomarkers in Patients with Persistent Diabetic Macular Edema Undergoing Cataract Surgery Combined with a Dexamethasone Intravitreal Implant. [PDF]

Bioengineering (Basel)
Fasolino G, Lazaar M, Della Rocca DG, Oellerich S, Ní Dhubhghaill S.   +4 more
europepmc   +1 more source

Long term efficacy and safety profile of dexamethasone intravitreal implant in retinal vein occlusions: a systematic review. [PDF]

Front Med (Lausanne)
Carnevali A, Bacherini D, Metrangolo C, Chiosi F, Viggiano P, Astarita C, Gallinaro V, Bonfiglio VME.   +7 more
europepmc   +1 more source

Dexamethasone Intravitreal Implant Is Active at the Molecular Level Eight Weeks after Implantation in Experimental Central Retinal Vein Occlusion. [PDF]

Molecules, 2022
Cehofski LJ, Kruse A, Mæng MO, Sejergaard BF, Schlosser A, Sorensen GL, Grauslund J, Honoré B, Vorum H.   +8 more
europepmc   +1 more source

Dexamethasone Intravitreal Implant to Treat Persistent Full-Thickness Macular Hole. [PDF]

J Vitreoretin Dis
Pellegrini F, Barosco G, Trento B, Rapizzi E, Zemella N.   +4 more
europepmc   +1 more source

Off-Label Use of 0.19 mg Fluocinolone Acetonide Intravitreal Implant: A Systematic Review. [PDF]

J Ophthalmol, 2021
Ribeiro F, Falcão MS.
europepmc   +1 more source